Skip to main content
. 2023 Jan 15;13(1):131. doi: 10.3390/metabo13010131

Table 2.

Multiple linear regression models of principal component score 1 (PC1) derived from metabolites with significantly different fold changes after the OGTT between T2D and control subjects vs. insulin sensitivity and obesity.

Standardized Beta p-Value 95% CI R2
Model 1
GluAUC −0.736 <0.001 [−0.30, −0.13]
HOMA-IR −0.010 0.950 [−0.46, 0.43]
BMI −0.222 0.098 [−0.36, 0.03]
0.61 ***
Model 2
HbA1c −0.463 0.003 [−0.30, −0.07]
HOMA-IR −0.289 0.068 [−0.85, 0.03]
BMI −0.132 0.379 [−0.32, 0.12]
0.47 ***

PC1: proportion of variance = 46.5%. Models are adjusted for sex and age. CI, confidence interval for unstandardized coefficient (lower bound, upper bound); GluAUC, glucose area under the curve; BMI, body mass index; HbA1c, glycosylated hemoglobin. Bold values indicate statistical significance. *** p < 0.001.